provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeDrugsBiologics
02:54

Switching From Biologics to Biosimilars: 4 Tips for Talking to Your Doctor

In some cases, you may save money by switching to a biosimilar.

Lauren Smith, MAMera Goodman, MD, FAAP
Written by Lauren Smith, MA | Reviewed by Mera Goodman, MD, FAAP
Published on November 16, 2023

Biologics are often more expensive than other medications. Sometimes, you may save some money by switching to a biosimilar, which may be highly similar to the original biologic (kind of like a generic version of a brand-name medication).

In this video, learn tips for talking to your doctor about switching between biologics and biosimilars, according to Stacia Woodcock, PharmD, Pharmacy Editor at GoodRx, and Alyssa Billingsley, PharmD, Director of Pharmacy Content at GoodRx.

Advertisement
Additional Medical Contributors (2)
  • Alyssa Billingsley, PharmDAlyssa Billingsley, PharmD, is a pharmacist on the GoodRx team with a decade of experience. She is also an adjunct faculty at St. Louis College of Pharmacy, where she graduated with a doctorate in pharmacy. She is licensed to practice in Missouri and is a member of the National Council of Prescription Drug Programs (NCPDP) and the Healthcare Information and Management Systems Society (HIMSS). Prior to GoodRx, Alyssa worked in both clinical and administrative roles. She was recognized with the Distinguished Alumnus Outstanding Achievement Award in 2017 for her work in developing pharmacy programs to expand patient access to quality medications.
    • Stacia Woodcock, PharmDStacia Woodcock, PharmD, is a pharmacy editor for GoodRx. She earned her Doctor of Pharmacy degree from the University of Kentucky and is licensed in New York and Massachusetts.

      References

      Federal Trade Commission. (2023). Are you on a biologic medication? What you need to know about biosimilar treatment options.

      U.S. Food and Drug Administration. (2023). Biosimilar basics for patients.

      GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

      Was this page helpful?

      Subscribe and save.

      Get prescription saving tips and more from GoodRx Health. Enter your email to sign up.

      By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.